Burden of migraine in the United States

Disability and economic costs

X. Henry Hu, Leona E. Markson, Richard B. Lipton, Walter F. Stewart, Marc L. Berger

Research output: Contribution to journalArticle

705 Citations (Scopus)

Abstract

Background: Migraine is a common disabling disease but its economic burden has not been adequately quantified. Objective: To estimate the burden of migraine in the United States with respect to disability and economic costs. Methods: The following data sources were used: published data, the Baltimore County Migraine Study, MEDSTAT's MarketScan medical claims data set, and statistics from the Census Bureau and the Bureau of Labor Statistics. Disability was expressed as bedridden days. Charges for migraine- related treatment were used as direct cost inputs. The human capital approach was used in the estimation of indirect costs. Results: Migraineurs required 3.8 bed rest days for men and 5.6 days for women each year, resulting in a total of 112 million bedridden days. Migraine costs American employers about $13 billion a year because of missed workdays and impaired work function; close to $8 billion was directly due to missed workdays. Patients of both sexes aged 30 to 49 years incurred higher indirect costs compared with younger or older employed patients. Annual direct medical costs for migraine care were about $1 billion and about $100 was spent per diagnosed patient. Physician office visits accounted for about 60% of all costs; in contrast, emergency department visits contributed less than 1% of the direct costs. Conclusions: The economic burden of migraine predominantly falls on patients and their employers in the form of bedridden days and lost productivity. Various screening and treatment regimens should be evaluated to identify opportunities to reduce the disease burden.

Original languageEnglish (US)
Pages (from-to)813-818
Number of pages6
JournalArchives of Internal Medicine
Volume159
Issue number8
DOIs
StatePublished - Apr 26 1999

Fingerprint

Migraine Disorders
Economics
Costs and Cost Analysis
Office Visits
Physicians' Offices
Baltimore
Bed Rest
Cost of Illness
Information Storage and Retrieval
Censuses
Health Care Costs
Hospital Emergency Service
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Burden of migraine in the United States : Disability and economic costs. / Hu, X. Henry; Markson, Leona E.; Lipton, Richard B.; Stewart, Walter F.; Berger, Marc L.

In: Archives of Internal Medicine, Vol. 159, No. 8, 26.04.1999, p. 813-818.

Research output: Contribution to journalArticle

Hu, X. Henry ; Markson, Leona E. ; Lipton, Richard B. ; Stewart, Walter F. ; Berger, Marc L. / Burden of migraine in the United States : Disability and economic costs. In: Archives of Internal Medicine. 1999 ; Vol. 159, No. 8. pp. 813-818.
@article{dcf4298dd5c242858105036f7f1ae39c,
title = "Burden of migraine in the United States: Disability and economic costs",
abstract = "Background: Migraine is a common disabling disease but its economic burden has not been adequately quantified. Objective: To estimate the burden of migraine in the United States with respect to disability and economic costs. Methods: The following data sources were used: published data, the Baltimore County Migraine Study, MEDSTAT's MarketScan medical claims data set, and statistics from the Census Bureau and the Bureau of Labor Statistics. Disability was expressed as bedridden days. Charges for migraine- related treatment were used as direct cost inputs. The human capital approach was used in the estimation of indirect costs. Results: Migraineurs required 3.8 bed rest days for men and 5.6 days for women each year, resulting in a total of 112 million bedridden days. Migraine costs American employers about $13 billion a year because of missed workdays and impaired work function; close to $8 billion was directly due to missed workdays. Patients of both sexes aged 30 to 49 years incurred higher indirect costs compared with younger or older employed patients. Annual direct medical costs for migraine care were about $1 billion and about $100 was spent per diagnosed patient. Physician office visits accounted for about 60{\%} of all costs; in contrast, emergency department visits contributed less than 1{\%} of the direct costs. Conclusions: The economic burden of migraine predominantly falls on patients and their employers in the form of bedridden days and lost productivity. Various screening and treatment regimens should be evaluated to identify opportunities to reduce the disease burden.",
author = "Hu, {X. Henry} and Markson, {Leona E.} and Lipton, {Richard B.} and Stewart, {Walter F.} and Berger, {Marc L.}",
year = "1999",
month = "4",
day = "26",
doi = "10.1001/archinte.159.8.813",
language = "English (US)",
volume = "159",
pages = "813--818",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "8",

}

TY - JOUR

T1 - Burden of migraine in the United States

T2 - Disability and economic costs

AU - Hu, X. Henry

AU - Markson, Leona E.

AU - Lipton, Richard B.

AU - Stewart, Walter F.

AU - Berger, Marc L.

PY - 1999/4/26

Y1 - 1999/4/26

N2 - Background: Migraine is a common disabling disease but its economic burden has not been adequately quantified. Objective: To estimate the burden of migraine in the United States with respect to disability and economic costs. Methods: The following data sources were used: published data, the Baltimore County Migraine Study, MEDSTAT's MarketScan medical claims data set, and statistics from the Census Bureau and the Bureau of Labor Statistics. Disability was expressed as bedridden days. Charges for migraine- related treatment were used as direct cost inputs. The human capital approach was used in the estimation of indirect costs. Results: Migraineurs required 3.8 bed rest days for men and 5.6 days for women each year, resulting in a total of 112 million bedridden days. Migraine costs American employers about $13 billion a year because of missed workdays and impaired work function; close to $8 billion was directly due to missed workdays. Patients of both sexes aged 30 to 49 years incurred higher indirect costs compared with younger or older employed patients. Annual direct medical costs for migraine care were about $1 billion and about $100 was spent per diagnosed patient. Physician office visits accounted for about 60% of all costs; in contrast, emergency department visits contributed less than 1% of the direct costs. Conclusions: The economic burden of migraine predominantly falls on patients and their employers in the form of bedridden days and lost productivity. Various screening and treatment regimens should be evaluated to identify opportunities to reduce the disease burden.

AB - Background: Migraine is a common disabling disease but its economic burden has not been adequately quantified. Objective: To estimate the burden of migraine in the United States with respect to disability and economic costs. Methods: The following data sources were used: published data, the Baltimore County Migraine Study, MEDSTAT's MarketScan medical claims data set, and statistics from the Census Bureau and the Bureau of Labor Statistics. Disability was expressed as bedridden days. Charges for migraine- related treatment were used as direct cost inputs. The human capital approach was used in the estimation of indirect costs. Results: Migraineurs required 3.8 bed rest days for men and 5.6 days for women each year, resulting in a total of 112 million bedridden days. Migraine costs American employers about $13 billion a year because of missed workdays and impaired work function; close to $8 billion was directly due to missed workdays. Patients of both sexes aged 30 to 49 years incurred higher indirect costs compared with younger or older employed patients. Annual direct medical costs for migraine care were about $1 billion and about $100 was spent per diagnosed patient. Physician office visits accounted for about 60% of all costs; in contrast, emergency department visits contributed less than 1% of the direct costs. Conclusions: The economic burden of migraine predominantly falls on patients and their employers in the form of bedridden days and lost productivity. Various screening and treatment regimens should be evaluated to identify opportunities to reduce the disease burden.

UR - http://www.scopus.com/inward/record.url?scp=0006913737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0006913737&partnerID=8YFLogxK

U2 - 10.1001/archinte.159.8.813

DO - 10.1001/archinte.159.8.813

M3 - Article

VL - 159

SP - 813

EP - 818

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 8

ER -